Supranuclear Palsy, Progressive

2

Review clinical trials related to Supranuclear Palsy, Progressive. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy

The objective of this proposal is to investigate the effect of non-invasive repetitive cerebellar transcranial magnetic stimulation (rTMS) on motor control in progressive supranuclear (PSP). The central hypothesis is that augmenting cerebellar inhibition via cerebellar rTMS will decrease postural instability in patients with PSP. We will use functional near infrared spectroscopy (fNIRS) to examine changes in motor and premotor cortical activity after cerebellar rTMS.

Participants needed: 30
Trial details
Age: 40-85Biological sex: AllType: InterventionalSponsor: Oregon Health and Science UniversityUpdated: May 29, 2025Locations: 1
Eligibility criteria

probable or possible PSP by the revised MDS PSP Criteria (Hoglinger 2017) [+7]

other significant neurological or vestibular disorders [+1]

Status: Recruiting

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations performed as part of normal clinical practice. Data collected from clinical evaluations, movement analysis, brain imaging, neuropsychological and electroencephalographic assessments, blood chemistry tests will be analysed to carry out statistical investigations and predictive analyses, also using artificial intelligence systems, which allow the identification of new early markers of diagnosis and prognosis of neurodegenerative diseases.

Participants needed: 600
Trial details
Age: 10+Biological sex: AllType: ObservationalSponsor: Casa di Cura San Raffaele CassinoUpdated: Sep 19, 2024Locations: 1
Eligibility criteria

Patients with diagnosis of Parkinson's Disease, Parkinsonism and Movement Disord... [+13]

There are no restrictions for participation in the study based on age, severity...